Kimberly-Clark Co. (NYSE:KMB - Free Report) - Research analysts at Zacks Research upped their FY2024 EPS estimates for shares of Kimberly-Clark in a report released on Tuesday, November 12th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $7.27 for the year, up from their previous estimate of $7.21. The consensus estimate for Kimberly-Clark's current full-year earnings is $7.26 per share. Zacks Research also issued estimates for Kimberly-Clark's Q4 2024 earnings at $1.47 EPS, Q1 2025 earnings at $1.97 EPS, Q2 2025 earnings at $1.87 EPS, Q3 2025 earnings at $1.86 EPS, Q4 2025 earnings at $1.82 EPS, FY2025 earnings at $7.52 EPS, Q1 2026 earnings at $2.09 EPS, Q2 2026 earnings at $1.97 EPS, Q3 2026 earnings at $1.95 EPS and FY2026 earnings at $7.75 EPS.
Kimberly-Clark (NYSE:KMB - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.14. The business had revenue of $4.95 billion for the quarter, compared to analyst estimates of $5.06 billion. Kimberly-Clark had a net margin of 12.97% and a return on equity of 198.59%. Kimberly-Clark's quarterly revenue was down 3.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.74 EPS.
KMB has been the topic of a number of other research reports. Argus raised shares of Kimberly-Clark to a "hold" rating in a research report on Friday, July 26th. Wells Fargo & Company cut their price objective on shares of Kimberly-Clark from $138.00 to $134.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 24th. UBS Group cut their price objective on shares of Kimberly-Clark from $153.00 to $151.00 and set a "neutral" rating on the stock in a research report on Wednesday, October 23rd. StockNews.com lowered shares of Kimberly-Clark from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, July 30th. Finally, Royal Bank of Canada reissued an "outperform" rating and issued a $165.00 price objective on shares of Kimberly-Clark in a research report on Wednesday, October 23rd. Two analysts have rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Kimberly-Clark has a consensus rating of "Hold" and an average price target of $149.93.
Read Our Latest Analysis on KMB
Kimberly-Clark Stock Down 0.0 %
Shares of NYSE:KMB traded down $0.01 during mid-day trading on Thursday, reaching $132.18. 828,219 shares of the stock were exchanged, compared to its average volume of 2,102,048. The company has a market cap of $44.08 billion, a P/E ratio of 17.15, a P/E/G ratio of 2.78 and a beta of 0.40. The stock's 50 day simple moving average is $140.08 and its 200-day simple moving average is $139.18. The company has a quick ratio of 0.55, a current ratio of 0.83 and a debt-to-equity ratio of 4.77. Kimberly-Clark has a one year low of $117.67 and a one year high of $149.30.
Kimberly-Clark Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Stockholders of record on Friday, December 6th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.69%. Kimberly-Clark's dividend payout ratio (DPR) is 63.29%.
Hedge Funds Weigh In On Kimberly-Clark
A number of large investors have recently modified their holdings of KMB. William B. Walkup & Associates Inc. purchased a new stake in Kimberly-Clark in the 2nd quarter worth about $26,000. Crewe Advisors LLC bought a new stake in Kimberly-Clark in the 1st quarter worth approximately $27,000. New Millennium Group LLC bought a new stake in Kimberly-Clark in the 2nd quarter worth approximately $28,000. Darwin Wealth Management LLC bought a new stake in Kimberly-Clark in the third quarter valued at approximately $29,000. Finally, Strategic Financial Concepts LLC bought a new stake in Kimberly-Clark in the second quarter valued at approximately $32,000. 76.29% of the stock is currently owned by institutional investors.
Kimberly-Clark Company Profile
(
Get Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
See Also
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.